These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24184665)

  • 1. Recent insights on the molecular mechanisms and therapeutic approaches for cardiac cachexia.
    Martins T; Vitorino R; Moreira-Gonçalves D; Amado F; Duarte JA; Ferreira R
    Clin Biochem; 2014 Jan; 47(1-2):8-15. PubMed ID: 24184665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study.
    Christensen HM; Kistorp C; Schou M; Keller N; Zerahn B; Frystyk J; Flyvbjerg A; Faber J
    Metabolism; 2014 Jan; 63(1):141-9. PubMed ID: 24140097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle wasting in cancer.
    Johns N; Stephens NA; Fearon KC
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2215-29. PubMed ID: 23770121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid-induced skeletal muscle atrophy.
    Schakman O; Kalista S; Barbé C; Loumaye A; Thissen JP
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2163-72. PubMed ID: 23806868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.
    Yoshida T; Tabony AM; Galvez S; Mitch WE; Higashi Y; Sukhanov S; Delafontaine P
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2322-32. PubMed ID: 23769949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic heart failure and cachexia: role of endocrine system].
    Dei Cas A; Muoio A; Zavaroni I
    Minerva Cardioangiol; 2011 Dec; 59(6):601-12. PubMed ID: 19946251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease.
    Langen RC; Gosker HR; Remels AH; Schols AM
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2245-56. PubMed ID: 23827718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns.
    Chatterton DE; Nguyen DN; Bering SB; Sangild PT
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1730-47. PubMed ID: 23660296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding cell death signals in liver inflammation.
    Brenner C; Galluzzi L; Kepp O; Kroemer G
    J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factors in preeclampsia: a vascular disease model. A failed vasodilation and angiogenic challenge from pregnancy onwards?
    Conti E; Zezza L; Ralli E; Caserta D; Musumeci MB; Moscarini M; Autore C; Volpe M
    Cytokine Growth Factor Rev; 2013 Oct; 24(5):411-25. PubMed ID: 23800655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum adipokine zinc α2-glycoprotein and lipolysis in cachectic and noncachectic heart failure patients: relationship with neurohormonal and inflammatory biomarkers.
    Tedeschi S; Pilotti E; Parenti E; Vicini V; Coghi P; Montanari A; Regolisti G; Fiaccadori E; Cabassi A
    Metabolism; 2012 Jan; 61(1):37-42. PubMed ID: 21696792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
    Mori J; Zhang L; Oudit GY; Lopaschuk GD
    J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac cachexia: a systematic overview.
    von Haehling S; Lainscak M; Springer J; Anker SD
    Pharmacol Ther; 2009 Mar; 121(3):227-52. PubMed ID: 19061914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune system and glucose metabolism interaction in schizophrenia: a chicken-egg dilemma.
    Steiner J; Bernstein HG; Schiltz K; Müller UJ; Westphal S; Drexhage HA; Bogerts B
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():287-94. PubMed ID: 23085507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Waste management - cytokines, growth factors and cachexia.
    Saini A; Al-Shanti N; Stewart CE
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):475-86. PubMed ID: 17118696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of melatonin on neurohormonal regulation in cardiac cachexia: A mechanistic review.
    Jafari-Vayghan H; Saleh-Ghadimi S; Maleki V; Moludi J; Alizadeh M
    J Cell Biochem; 2019 Oct; 120(10):16340-16351. PubMed ID: 31168891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology-based novel pharmacotherapy for heart failure with preserved ejection fraction.
    Konstantinou DM; Chatzizisis YS; Giannoglou GD
    Pharmacol Ther; 2013 Nov; 140(2):156-66. PubMed ID: 23792088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-I and insulin regulate eIF4F formation by different mechanisms in muscle and liver in the ovine fetus.
    Shen W; Mallon D; Boyle DW; Liechty EA
    Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E593-603. PubMed ID: 12169454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal consequences and prognosis of chronic heart failure.
    Attanasio P; Anker SD; Doehner W; von Haehling S
    Curr Opin Endocrinol Diabetes Obes; 2011 Jun; 18(3):224-30. PubMed ID: 21494135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.